Synchronous fluorescence as a green and selective tool for simultaneous determination of bambuterol and its main degradation product, terbutaline

被引:18
作者
El Abass, Samah Abo [1 ,2 ]
Elmansi, Heba [1 ]
机构
[1] Mansoura Univ, Fac Pharm, Dept Pharmaceut Analyt Chem, Mansoura 35516, Egypt
[2] Delta Univ Sci & Technol, Fac Pharm, Dept Pharmaceut Chem, Gamasa 35715, Egypt
来源
ROYAL SOCIETY OPEN SCIENCE | 2018年 / 5卷 / 10期
关键词
terbutaline; bambuterol; derivative; synchronous; spectrofluorimetric; PLASMA; URINE;
D O I
10.1098/rsos.181359
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A green, sensitive and cost-effective method is introduced in this research for the determination of bambuterol and its main degradation product, terbutaline, simultaneously, relying on the synchronous spectrofluorimetric technique. First derivative synchronous spectrofluorimetric amplitude is measured at Delta lambda = 20 nm, so bambuterol can be quantitated at 260 nm, and terbutaline can be measured at 290 nm, each at the zero crossing point of the other. The amplitude-concentration plots were linear over the concentration ranges of 0.2-6.0 mu g ml(-1) and 0.2-4.0 mu g ml(-1) for both bambuterol and terbutaline, respectively. Official guidelines were followed to calculate the validation parameters of the proposed method. The low values of limits of detection of 0.023, 0.056 mu g ml(-1) and limits of quantitation of 0.071, 0.169 mu g ml(-1) for bambuterol and terbutaline, respectively, point to the sensitivity of the method. Bambuterol is a prodrug for terbutaline, and the latter is considered its degradation product so the established method could be regarded as a stability-indicating one. Moreover, the proposed method was used for the analysis of bambuterol and terbutaline in their single ingredient preparations and the results revealed statistical agreement with the reference method. The suggested method, being a simple and low-cost procedure, is superior to the previously published methods which need more sophisticated techniques, longer analysis time and highly toxic solvents and reagents. It could be considered as an eco-friendly analytical procedure.
引用
收藏
页数:12
相关论文
共 16 条
  • [1] Applications of micelle enhancement in luminescence-based analysis
    Alarfaj, Nawal A.
    El-Tohamy, Maha F.
    [J]. LUMINESCENCE, 2015, 30 (01) : 3 - 11
  • [2] Critical approach to synchronous spectrofluorimetry. I
    Andrade-Eiroa, Aurea
    de-Armas, Graciela
    Estela, Jose-Manuel
    Cerda, Victor
    [J]. TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2010, 29 (08) : 885 - 901
  • [3] APPLICATION OF SYNCHRONOUS EXCITATION SPECTROFLUORIMETRY TO DRUG ANALYSIS
    ANDRE, JC
    BAUDOT, P
    NICLAUSE, M
    [J]. CLINICA CHIMICA ACTA, 1977, 76 (01) : 55 - 66
  • [4] SPECTROFLUORIMETRIC AND SYNCHRONOUS SCANNING FIRST DERIVATIVE SPECTROFLUORIMETRY FOR DETERMINATION OF MAGNESIUM WITH SALICYLALDEHYDE 2-PYRIDYLHYDRAZONE
    BLANCO, CC
    SANCHEZ, FG
    [J]. ANALYTICAL CHEMISTRY, 1984, 56 (12) : 2035 - 2038
  • [5] Brayfield A., 2013, Martindale: The Complete Drug Reference
  • [6] British Pharmacopoeia Commission, 2009, BRIT PHARMACOPOEIA, VVolume 3
  • [7] Elmansi H, 2018, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.87443g0, DOI 10.5061/DRYAD.87443G0]
  • [8] Application of A New Spectrophotometric Method Manipulating Ratio Spectra for Determination of Bambuterol Hydrochloride in the Presence of Its Degradation Product Terbutaline
    Lamie, Nesrine T.
    [J]. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2015, 35 (01) : 151 - 156
  • [9] DETERMINATION OF BAMBUTEROL, A PRODRUG OF TERBUTALINE, IN PLASMA AND URINE BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY
    LINDBERG, C
    JONSSON, S
    PAULSON, J
    TUNEK, A
    [J]. BIOMEDICAL AND ENVIRONMENTAL MASS SPECTROMETRY, 1990, 19 (04): : 218 - 224
  • [10] Simultaneous analysis of bambuterol and its active metabolite terbutaline enantiomers in rat plasma by chiral liquid chromatography-tandem mass spectrometry
    Luo, Wenxia
    Zhu, Lin
    Deng, Jifeng
    Liu, Aiming
    Guo, Bin
    Tan, Wen
    Da, Renke
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2010, 52 (02) : 227 - 231